226 related articles for article (PubMed ID: 19399493)
1. Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor.
Tae H; Casarotto MG; Dulhunty AF
Eur Biophys J; 2009 Dec; 39(1):51-9. PubMed ID: 19399493
[TBL] [Abstract][Full Text] [Related]
2. The elusive role of the SPRY2 domain in RyR1.
Tae H; Wei L; Willemse H; Mirza S; Gallant EM; Board PG; Dirksen RT; Casarotto MG; Dulhunty A
Channels (Austin); 2011; 5(2):148-60. PubMed ID: 21239886
[TBL] [Abstract][Full Text] [Related]
3. A dihydropyridine receptor alpha1s loop region critical for skeletal muscle contraction is intrinsically unstructured and binds to a SPRY domain of the type 1 ryanodine receptor.
Cui Y; Tae HS; Norris NC; Karunasekara Y; Pouliquin P; Board PG; Dulhunty AF; Casarotto MG
Int J Biochem Cell Biol; 2009 Mar; 41(3):677-86. PubMed ID: 18761102
[TBL] [Abstract][Full Text] [Related]
4. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor.
Leong P; MacLennan DH
J Biol Chem; 1998 Apr; 273(14):7791-4. PubMed ID: 9525869
[TBL] [Abstract][Full Text] [Related]
5. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor.
Leong P; MacLennan DH
J Biol Chem; 1998 Nov; 273(45):29958-64. PubMed ID: 9792715
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition of the disordered dihydropyridine receptor II-III loop by a conserved spry domain of the type 1 ryanodine receptor.
Tae HS; Norris NC; Cui Y; Karunasekara Y; Board PG; Dulhunty AF; Casarotto MG
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):346-9. PubMed ID: 19076161
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor.
Hayek SM; Zhu X; Bhat MB; Zhao J; Takeshima H; Valdivia HH; Ma J
Biochem J; 2000 Oct; 351(Pt 1):57-65. PubMed ID: 10998347
[TBL] [Abstract][Full Text] [Related]
8. 3D Mapping of the SPRY2 domain of ryanodine receptor 1 by single-particle cryo-EM.
Perálvarez-Marín A; Tae H; Board PG; Casarotto MG; Dulhunty AF; Samsó M
PLoS One; 2011; 6(10):e25813. PubMed ID: 21998699
[TBL] [Abstract][Full Text] [Related]
9. Imperatoxin a enhances Ca(2+) release in developing skeletal muscle containing ryanodine receptor type 3.
Nabhani T; Zhu X; Simeoni I; Sorrentino V; Valdivia HH; García J
Biophys J; 2002 Mar; 82(3):1319-28. PubMed ID: 11867448
[TBL] [Abstract][Full Text] [Related]
10. An α-helical C-terminal tail segment of the skeletal L-type Ca2+ channel β1a subunit activates ryanodine receptor type 1 via a hydrophobic surface.
Karunasekara Y; Rebbeck RT; Weaver LM; Board PG; Dulhunty AF; Casarotto MG
FASEB J; 2012 Dec; 26(12):5049-59. PubMed ID: 22962299
[TBL] [Abstract][Full Text] [Related]
11. Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor.
Mei Y; Xu L; Mowrey DD; Mendez Giraldez R; Wang Y; Pasek DA; Dokholyan NV; Meissner G
J Biol Chem; 2015 Jul; 290(28):17535-45. PubMed ID: 25998124
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1.
Fessenden JD; Feng W; Pessah IN; Allen PD
J Biol Chem; 2004 Dec; 279(51):53028-35. PubMed ID: 15469935
[TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
Gomez AC; Holford TW; Yamaguchi N
Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
[TBL] [Abstract][Full Text] [Related]
14. RYR1 and RYR3 have different roles in the assembly of calcium release units of skeletal muscle.
Protasi F; Takekura H; Wang Y; Chen SR; Meissner G; Allen PD; Franzini-Armstrong C
Biophys J; 2000 Nov; 79(5):2494-508. PubMed ID: 11053125
[TBL] [Abstract][Full Text] [Related]
15. A central core disease mutation in the Ca
Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
[TBL] [Abstract][Full Text] [Related]
16. A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction.
Kimura T; Pace SM; Wei L; Beard NA; Dirksen RT; Dulhunty AF
Biochem J; 2007 Jan; 401(1):317-24. PubMed ID: 16989644
[TBL] [Abstract][Full Text] [Related]
17. FKBP12 modulation of the binding of the skeletal ryanodine receptor onto the II-III loop of the dihydropyridine receptor.
O'Reilly FM; Robert M; Jona I; Szegedi C; Albrieux M; Geib S; De Waard M; Villaz M; Ronjat M
Biophys J; 2002 Jan; 82(1 Pt 1):145-55. PubMed ID: 11751303
[TBL] [Abstract][Full Text] [Related]
18. Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor.
Kobayashi S; Yamamoto T; Parness J; Ikemoto N
Biochem J; 2004 Jun; 380(Pt 2):561-9. PubMed ID: 15027895
[TBL] [Abstract][Full Text] [Related]
19. Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin.
Lee JM; Rho SH; Shin DW; Cho C; Park WJ; Eom SH; Ma J; Kim DH
J Biol Chem; 2004 Feb; 279(8):6994-7000. PubMed ID: 14638677
[TBL] [Abstract][Full Text] [Related]
20. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.
Altafaj X; Cheng W; Estève E; Urbani J; Grunwald D; Sabatier JM; Coronado R; De Waard M; Ronjat M
J Biol Chem; 2005 Feb; 280(6):4013-6. PubMed ID: 15591063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
